SBC Medical Group Holdings Incorporated
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| – | +14.8% | +2.8% | +43.0% | |
| – | +46.9% | +11.2% | +25.4% | |
| – | +99.1% | +21.4% | +31.0% | |
| – | +92.0% | +21.4% | +31.2% | |
| – | +21.7% | -9.3% | +10.2% | |
| – | +128.9% | -51.6% | +86.8% | |
| – | -7.1% | +28.5% | +234.5% | |
| – | +171.5% | -91.9% | +2,902.6% | |
| – | -2.2% | -38.2% | +64.8% | |
| – | -8.7% | -33.8% | -0.1% | |
| – | -10.1% | -39.8% | +205.7% | |
| – | +73.2% | -45.2% | +21.4% | |
| – | +135.3% | -50.0% | +418.4% | |
| – | +35.1% | +37.2% | +27.3% | |
| – | +38.0% | +32.6% | +26.9% | |
| – | +525.2% | +2.5% | +6.7% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.